"In light of this research, we urge the FDA to reinstate earlier, stronger patient safety protocols and reconsider its approval of mifepristone altogether. Women deserve better than the abortion pill," urged the study's authors Ryan Anderson and Jamie Bryan Hall.

"Simply stated, mifepristone, as used in real-world conditions, is not 'safe and effective,'" they added.

Hall added that women who experience what's called an "adverse event" will likely end up in the ER or hospitalized overnight. "It's very risky for her in these situations to be doing this without proper care from a physician throughout the process."

Researchers and pro-life groups say that both the EPPC and CLI studies reveal that abortion providers are harming the women they say they are championing, especially when they encourage women to lie when they go into the ER.

"The abortion industry's push for concealment is unethical and dangerous," said Dr. Studnicki. "Women deserve honest guidance and proper medical care, not advice that jeopardizes their health."